As US Research Recedes, What is Future of Biotech in Europe?
At the 2025 BIO Europe Summit, David Lowe, CEO of Ipsen, and Jeremy Levin, Chairman Emeritus of BIO, explored...
Bridging the Early-Stage Biotech Gap: Inside the Johnson & Johnson Partnering Ecosystem
At the Bio-Europe conference, leadership from Johnson & Johnson (J&J) provided an in-depth roadmap for navigating the pharmaceutical giant’s...
Compliance and Creativity Converge as MLR Reframes Modern Medical Content
In the ever-evolving landscape of the pharmaceutical and MedTech industries, balancing compliance with creativity is a crucial challenge. This...
Is Pharma Ready for Embedded AI? The 30% Productivity Frontier
At the 2025 Veeva Commercial Summit in Madrid, life sciences leaders convened to explore how generative and agentic AI...
FDA’s OTP Town Hall Clarifies CMC and Facility Readiness Standards for Gene Therapy BLAs
The FDA’s Office of Therapeutic Products (OTP) within the Center for Biologics Evaluation and Research (CBER) hosted its Virtual...
FDA’s 2025 Roadmap for Generics: Modernizing Policy, Transparency, and Global Alignment
At the Advancing Generics 2025 forum, FDA officials, policy leaders, and industry executives outlined the next phase of the...